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A malignant tumor is thought to represent the proliferation of a clone of cells arising 
from a single transformed cell (1). Evidence for this concept has come from three different 
approaches: karyotype analysis,  isoenzyme patterns,  and immunoglobulin expression. 
All of these approaches have limitations, but when they have been employed, they have 
generally supported the concept of malignant growth being monoclonal. The only excep- 
tions to this rule have been the tumors arising as a result of a dominant genetic trait, 
such  as  neurofibromatosis  or trichoepitheliomata,  where  it  is  thought  that  multiple 
primary tumors  exist  side  by side  within  the  same tumor  nodule  (2,  3).  Karyotype 
analyses of tumor cells have occasionally disclosed a stable chromosome marker that can 
serve to identify a particular clone of cells (4, 5). Isoenzyme patterns of tumor cells have 
been examined in patients who are female and heterozygous for an X-linked enzyme, 
such as glucose-6-phosphate dehydrogenase. Since, according to the Lyon hypothesis (6), 
each somatic cell expresses only one X chromosome, normal tissues of heterozygotes are 
composed of mosaics of cells expressing alternate forms of the enzyme. The finding of 
uniform expression of a single isoenzyme within a tumor cell population indicates that 
the entire population is derived from a single cell (1). Similarly, the immunoglobulin type 
of lymphoid malignancies  can  be examined for its  uniformity  among the  tumor cell 
population (7-12). The immunoglobulin producing lymphoid neoplasms provide a special 
opportunity to test the concept of monoclonality.  All of these tumors are suitable for 
analysis, not just the ones that have a  definable chromosome marker or that occur in 
females who happen to be heterozygous for an X-linked enzyme. 
Individual differentiated lymphoid cells are restricted in their potential for immuno- 
globulin expression and these restrictions are stable within their clonal descendents (13). 
These restrictions are somewhat more relaxed than was once believed to be the case. For 
instance,  a  single cell can give rise to cells that produce immunoglobulin of different 
heavy chain classes (14). However, the Ig products of the same clone all contain a single 
VH and  VL region  and  a  single  light  chain  of either  K or  ~t  type  (13-19).  Thus,  the 
monoclonality of a  population  of malignant  lymphoid  cells  can be inferred  from its 
uniform restriction to a single light chain type. 
In  the  example  of Ig-secreting lymphoid  tumors,  such  as  multiple  myeloma and 
WaldenstrSm's macroglobulinemia, monoclonality is easily established by an examina- 
tion of the secreted product.  However, it has now become clear that a number of other 
types of lymphoid neoplasms produce, but do not necessarily secrete, Ig. The best-known 
example of the latter is chronic lymphocytic leukemia (CLL).1 Here a number of careful 
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studies have established that the Ig found on the surface of the CLL cell is produced by 
that cell and is restricted to a single light chain type (8, 9, 17-19). For example, in a given 
patient  with  CLL, all the  leukemic cells  will  have  either  K or ~-type Ig on their  cell 
surface, whereas normal human lymphoid populations consist of  a mosaic of K-containing 
and k-containing cells in a ratio of approximately 2:1. Interestingly, the same CLL cell 
may have cell surface Ig of both IgM and IgD, but both the IgM and the IgD share a 
common idiotype, indicating that a  single heavy chain variable region can be joined to 
different constant regions (19). Hence, the monoclonality of CLL is well established. 
In  addition  to  CLL  a  number  of other  human  lymphoproliferative  disorders  are 
characterized by the production, but rarely the secretion, of Ig. This growing list includes 
lymphosarcoma cell leukemia, hairy cell leukemia, well-differentiated lymphocytic lym- 
phomas, nodular poorly differentiated lymphocytic lymphoma, and some cases of'histio- 
cytic" lymphoma (9-12, 20). In some of these diseases there is evidence of monoclonality 
based  on  K or ~  uniformity of the  tumor  cells.  In the  cases  of lymphoma  (i.e.,  solid 
lymphoid tumors)  the  evidence  comes from studies  on  cell  suspensions  derived  from 
involved tissues  (9-12, 20); however, when cell suspensions are prepared,  one loses the 
information contained in the details of tissue architecture. As a consequence, only tissues 
that are massively replaced by tumor cells are suitable for such analysis, since in order to 
be apparent,  the monoclonal population must perturb the normal K#, ratio.  This same 
limitation applies to isoenzyme analyses, also usually performed in tissue homogenates. 
In  the  present  study  we  have  applied  techniques  for  immunofluorescent 
staining  of lymphoma  cells  in  tissue  sections.  The  ability  to  examine  the 
clonality of human  lymphomas in situ should provide a  more sensitive approach 
to the investigation  of the immunobiology of these diseases. 
Materials and Methods 
All chemicals were reagent grade. Pepsin was obtained from Worthington Biochemical Corp., 
Freehold, N. J. DEAE cellulose  (DE52) was obtained from Whatman, Inc., Clifton, N. J. Acrylam- 
ide,  bisacrylamide, TEMED  (NNN'N' tetramethylethylene diamine) and CNBr were obtained 
from Eastman Kodak Co., Rochester, N. Y. Sepharose 4B and Sephadex were from Pharmacia 
Fine Chemicals, Div. of Pharmacia Inc., Piscataway, N. J. 
Immunoabsorbents.  Immunoabsorbents were prepared by reacting proteins with CNBr-acti- 
vated Sepharose 4B (21). 5-20 mg of protein were coupled to 1 g packed wet Sepharose. Antibodies 
were eluted from the absorbents with 0.1 N NH4OH. 
Polyacrylamide Gel Electrophoresis.  Polyacrylamide gel electrophoresis in the presence of 2- 
mercaptoethanol and sodium dodecyl sulfate was performed in gradient slab cells as described by 
Laemmli (22). 
Immunoglobulin  Reagents 
All immunofiuorescence studies were performed with F(ab')2 fragments of purified antibodies. 
These reagents were prepared as follows: 
IMMUNOGENS.  Human K and k Bence Jones proteins were isolated from the urine of patients 
(one each) with multiple myeloma by precipitation with (NH4hSO4 at 55% saturation, followed by 
gel filtration on Sephadex G-75 superfine. These purified light chain preparations, when analyzed 
by polyacrylamide gel electrophoresis in sodium dodecyl sulfate (SDS-PAGE), migrated in a single 
sharp band even on overloaded gels.  F(ab')2 fragments of human K and of human ~, IgG myeloma 
proteins were prepared from a pool of seven sera each (obtained from Dr.  M. Lahav, Sick Fund 
Organization, Central Laboratory, Tel Aviv). Their globulin fractions were obtained by precipita- 
tion with  (NH4)2SO4 at 35% saturation.  IgG was isolated by ion exchange chromatography on 
FITC, fluorescein isothiocyanate; PBS, phosphate-buffered saline (0.14 M NaC1, 0.01 M KH2PO4, 
pH  7.4); RITC,  rhodamine  isothiocyanate;  SDS-PAGE, polyacrylamide gel  electrophoresis  in 
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DEAE cellulose (23) and the F(ab')2 fragments were prepared by pepsin (24) digestion with a ratio 
of 2% enzyme:substrate by weight and a 24-h incubation at 37°C in 0.1 M sodium acetate, pH 4.5. 
The digestion was stopped by the addition of saturated Tris buffer to bring the pH to 8.0 and the 
reactants  and products were separated by gel filtration on Sephadex G-200.  The final products 
gave no reaction by Ouchterlony analysis (25) with a goat antiserum specific for the Fc fragment of 
human 7 chains. They likewise showed no heavy chain contamination by SDS-PAGE analysis. 
ANTISERA, ANTIBODIES,  AND  F(ab~)2 FRAGMENTS.  Anti-x and anti-~, antisera were prepared in 
goats by repeated  intradermal  injections of antigen emulsified in complete Freund's adjuvant. 
Each immunization consisted of 1 mg of antigen divided into multiple intradermal sites. After a 
course of four monthly immunizations with purified Bence Jones proteins,  the antisera,  while 
specific  for  x  or  ~,  reacted  primarily  with  free  light  chains  and  very  poorly  with  whole  Ig 
molecules. Accordingly, the animals were boosted with a series of three biweekly injections of the 
F(ab')~ fragments of appropriate light chain type, prepared as described above. 
The IgG fraction from the serum of the goat immunized with the K Bence Jones protein and the 
F(ab')~ fragments of K myeloma proteins was passed over an IgG-~ myeloma-Sepharose immu- 
noabsorbent to remove anti-Fd activities. Anti-~ antibodies were then purified from the material 
that passed through the absorbent, on an IgG-K myeloma-Sepharose column. Serum from the goat 
immunized with the ~, Bence Jones protein and F (ab')2 fragments of ~ myeloma proteins had a low 
titer of anti-~, antibodies.  Thus,  it was first applied to an IgG-~ myeloma-Sepharose column to 
concentrate the antibodies, which were then eluted and rendered specific by absorption on IgG-K 
myeloma-Sepharose. Both the purified anti-x and anti-~, antibodies reacted strongly by Ouchter- 
lony analysis with myeloma proteins of their respective types and with normal Ig, and they were 
specific for x and ~,, respectively. Their specificity was further characterized by radioimmunoassay 
(26). Briefly, purified myeloma proteins of either K or k type were labeled with 12sI (27) and the 
binding of 125I-Ig to the goat antibodies was determined by indirect immunoprecipitation.  Solu- 
tions containing 0.5 #tl of normal goat serum and various amounts of antibody were mixed with 
l~SI-labeled myeloma protein (2-10 ng; 10,000 cpm) and incubated for 2 h at 24°C. Rabbit anti-goat 
IgG serum was added to the reaction mixtures and incubation was extended another 15-20 h  at 
4°C.  Radioactivity was then determined in the washed precipitates.  The rabbit anti-goat Ig and 
the normal goat serum used for these  assays  were first absorbed  on a  normal human  serum- 
Sepharose immunoabsorbent.  By this assay, the purified anti-x and anti-~, antibodies were found 
to have specificity ratios of greater than 103, i.e., maximal binding of homologous Ig type occurred 
at an antibody concentration less than  1/1,000  of that necessary to see any binding of Ig of the 
opposite light chain type. 
F(ab')~ fragments of the purified goat antibodies were prepared by pepsin digestion.  Optimal 
conditions for pepsin digestion of goat IgG were found to be different from those for human IgG. 
The intention here was to achieve complete digestion while minimizing loss of antibody activity. 
The final conditions employed included an enzyme-to-substrate ratio of 4%,  a  solution 0.2 M in 
acetate, a pH of 4.25, and an incubation time of 15 h  at 24°C. 
Immunofluorescence 
Conjugated  F(ab')2  fragments  of purified  anti-x  and  anti-k  antibodies  were  used  for direct 
immunofluorescence. They were conjugated with tetramethylrhodamine isothiocyanate (RITC) or 
fluorescein isothiocyanate (FITC) as described by Cebra and Goldstein (28). The conjugates used 
had dye:protein ratios of 2-3 mol/mol. 
Cell Suspensions 
Human lymphoblastoid cell lines MOLT,  a  T-cell line  (29), and SB, a  B-cell line  (30),  were 
obtained  from  Dr.  Ivor  Royston  and  grown  in  RPMI  1640 containing  10%  fetal  calf serum. 
Peripheral blood lymphocytes were isolated from normal human  donors or from patients  with 
leukemia  by  density  sedimentation  in  Ficoll-Hypaque (31).  Cells were  washed  in  phosphate- 
buffered saline (PBS) and then incubated 18-24 h in Eagle's minimum essential medium contain- 
ing 5% fetal calf serum (FCS) to allow the shedding of passively absorbed serum Ig. 106 cells were 
incubated with appropriate dilutions of F(ab')2 fragments of anti-K and anti-~,  for 30 rain at 4°C. 
The cells were then washed by centrifugation through a layer of decomplemented FCS, smeared on 
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Tissue Sections 
SOURCE AND  PREPARATION OF  TISSUE.  Human lymphoid tissues were obtained immediately 
after surgical removal. Adipose tissue was carefully trimmed from lymph nodes. Representative 
blocks were embedded in mounting medium (OCT compound, Tissue Tek II; Lab-Tek Products, 
Div. Miles Laboratories Inc., Naperville, Ill.) and frozen in a  mixture of isopentane and dry ice. 
The blocks were frozen and stored in air-tight plastic capsules at  -70°C before being sectioned. 
Frozen sections were prepared for immunofluorescence essentially by the method described by 
Gutman and Weissman (32). The sections were cut at 4-6 ~m and fixed immediately in acetone for 
less than 5 s. 
STAINING OF SECTIONS.  Tissue sections on glass slides were washed for 5 min in PBS with 5% 
fetal calf serum, pH 7.4 (PBS +  5% FCS). Excess wash solution was wiped from the slides, which 
were then incubated with fluorescent antibody fragments for 10 rain at 37°C. The slides were then 
washed for 5 min in PBS +  5% FCS and subsequently with normal saline. The slides were then 
mounted in Tris-buffered glycerol, pH 9.2. 
Immunofluorescence Microscopy  and Photomicrography 
Sections and smears were examined in a Zeiss microscope equipped with vertical illumination 
(Carl  Zeiss,  Inc.,  New  York)  with an  HBO  50  mercury  vapor lamp  and  exciter barrier filter 
combinations for fluorescein 440-490-nm excitation or rhodamine 546.1-nm excitation. Black-and- 
white photographs were taken with a Polaroid camera (Polaroid Corp., Cambridge, Mass.). Color 
slides were taken with a  Zeiss 35-mm camera on high speed Ektachrome (Eastman Kodak Co.), 
with ESP-1 processing (ASA-400). 
Results 
Cell Suspensions.  Viable cell suspensions from human lymphoblastoid cell 
lines or from peripheral blood lymphocytes  were examined by direct immunoflu- 
orescence  for  cell  surface  Ig  of K or  k  type,  as  described  in  Materials  and 
Methods. 
Staining was performed with a mixed reagent consisting of F(ab')2 fragments 
of fluorescein-labeled anti-K and rhodamine-labeled anti-k. Each cell could then 
be individually examined for K and for ~.  We found that for peripheral blood 
lymphocytes a  critical step was an incubation of the cells in a  medium free of 
human serum proteins before staining (Table I) (33).  5 Thus, when staining was 
performed on freshly isolated cells, the total percentage of cells showing surface 
Ig was approximately 35%; however, the majority of these cells were positive 
both of K and for ~,. This staining occurred in a beaded membrane pattern with 
individual beads showing staining for both K and k. After incubation at 37°C in 
tissue culture medium free of human serum,  which presumably allowed the 
shedding of passively absorbed serum Ig (33),  5  the total percentage of Ig-positive 
cells fell to less than 10% with no double-staining cells. No significant loss of cell 
viability occurred during incubation. The shedding process was somewhat de- 
pendent upon temperature since incubation at 4°C resulted in a residual popula- 
tion of 4% double-stained cells. Incubation in the presence of autologous plasma 
at 4°C resulted in an increase  in double-staining cells to as high as 60%. All 
subsequent results with peripheral blood lymphocytes were, therefore, derived 
from experiments in which the cells were incubated overnight at 37°C in tissue 
culture medium before staining. 
The results of K-k staining of  cells from a variety of sources are shown in Table 
2 Hofman, F., A.  Cohen, D.  Zipori, R.  Burstein, Z. Bentwick, and J. Haimovich.  1976.  Mem- 
brane Ig and auto-antibodies to lymphocyte membrane. Manuscript submitted for publication. 1018  MONOCLONALITY  OF  HUMAN  B-CELL  LYMPHOMAS 
TABLE  I 
Effects of Various Incubations 
Incubation 
Cells Staining 
K  k  Double 
None 
4°C,  18 h  Jn autologous plasma 
4°C,  18 h  in RPMI +  5% FCS 
37°C,  18 h  in RPMI +  5% FCS 
%  %  % 
36  29  24 
63  66  59 
8  6  4 
4  3  0 
Normal peripheral blood lymphocytes were isolated by the Ficoll-Hy- 
paque technique and washed in PBS. After incubation, 106 cells were 
stained at 4°C with a  mixed fluorescein-labeled anti-K and rhodamine- 
labeled anti-L After washing and fixing on slides, the cells were exam- 
ined for both fluorescein and rhodamine fluorescence  with a Zeiss micro- 
scope equipped with incidence illumination. 
II. SB, a human B lymphoblastoid cell line, gave exclusive staining for K, while 
MOLT, a T lymphoblastoid line, gave staining for neither. Likewise, the periph- 
eral  blood cells from a  patient  with  acute lymphoblastic leukemia  were uni- 
formly negative  for Ig.  14-cases  of CLL  were  examined,  with  13  showing  a 
monoclonal staining pattern  (8K and 5k) and 1 negative for Ig. Cells from three 
patients  with  lymphosarcoma  cell  leukemia  and  one  patient  with  hairy  cell 
leukemia gave monoclonal Ig staining.  These results on viable cell suspensions 
confirmed other reports (8, 9, 33-35) and served to validate the immunofluores- 
cent reagents. 
Tissue Sections.  Cryostat sections of normal lymph nodes were stained with 
the mixed anti-K and anti-k antibody fragments. Lymphoid follicles (Fig. 1) were 
evident not only by their Ig positivity but by their pattern of staining.  Toward 
the  center  of the  secondary follicles there  was a  variable  amount  of densely 
staining Ig distributed in a lacy pattern.  This material always stained positive, 
both for K and for k and, therefore, represented extracellular protein. The cells of 
the mantle, most of which were small lymphocytes, were composed of a mixture 
of K-staining and k-staining cells. Most of the cells could easily be distinguished 
as staining either for K or for k but not for both (Figs.  1 and 2). Because of the 
scant amount of cytoplasm in these cells it was not usually possible to determine 
whether  Ig staining  was limited  to the  membrane  or  was also intracellular. 
However, in the  case of plasma  cells,  where cytoplasm could easily be seen, 
there was bright intracellular staining which once again was restricted either to 
K or to k in individual cells. In normal lymphoid tissues the number of K-staining 
cells was always greater than the number of k-staining cells. 
A totally different pattern of staining was found in lymphoid tissues involved 
by lymphoma.  In Fig.  3 is shown an  example of a  lymph node from a  case of 
diffuse, well-differentiated lymphocytic lymphoma.  As can be seen, the entire 
tissue was composed of small lymphoid cells that stained uniformly for K; no k- 
staining  cells  were seen.  This  finding  of exclusive  K staining  was confirmed 
when the fluorescent labels were reversed, i.e.,  employing fluorescein-labeled 
anti-k and rhodamine-labeled anti-K. In a second example (Fig. 4), a spleen from R.  LEVY,  R.  WARNKE,  R.  F.  DORFMAN,  AND  J.  HAIMOVICH 
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Results of K-~ Staining on a Variety of Cells 
1019 
Source of cells 
Cells staining 
~,  Neither 
% 
Normal peripheral blood lymphocytes  4-6 
Lymphoblastoid cell line SB  86 
Lymphoblastoid cell line MOLT  0 
Acute lymphoblastic leukemia  0 
%  % 
3--4  90-93 
0  14 
0  100 
0  100 
Number of cases 
Cases with >85% of cells staining 
Exclusively K 
Chronic lymphocytic leukemia  8 
Lymphosarcoma cell leukemia  1 
Hairy cell leukemia  0 
Exclusively k  Neither 
5  1 
2  0 
1  0 
a case of hairy cell leukemia, the converse pattern of staining was noted. Here, 
no K-staining cells were seen, but instead the tissue was diffusely infiltrated by 
cells staining exclusively for ~,. In Fig. 5 is shown an example of a lymph node 
from a  case of nodular poorly differentiated lymphocytic lymphoma.  Here, the 
nodule of lymphoma was composed of cells staining exclusively for K. It should 
be noted  that  in  this  case  not  all  of the  cells  within  the  lymphoma  nodule 
contained  Ig.  Another  example  of nodular  poorly differentiated  lymphocytic 
lymphoma is shown in Fig. 6. Here, the connective tissue, which shows autofluo- 
rescence,  accentuated  the  boundaries  of the  nodules.  Once  again,  there  was 
exclusive light chain staining of the cells, this time with K. In this example the 
node  was  totally replaced  by lymphoma  and  no residual  polyclonal  staining 
normal tissue was evident outside the nodules. 
In addition to the examples illustrated  here,  a  total of 12 consecutive lym- 
phoma patients  have been examined,  including  10 cases of lymphocytic lym- 
phoma and 2 cases of"histiocytic" lymphoma. None of the patients in this group 
had an  M-component in the serum to confuse the analysis of tissue Ig.  All of 
these lymphomas were composed of immunoglobulin-bearing cells restricted in 
light chain type, with a total of seven cases of K type and five cases of k type. In 
each instance the assignment of light chain type was confirmed by reversing the 
color of the  reagents  as  described  above.  Furthermore,  when  multiple  focal 
areas of lymphoma were present within a given tissue or when different tissue 
sites were examined from a given patient, they were always composed of cells of 
a  consistent light  chain  type; hence all of the disease in a  given patient  was 
presumably derived from the same clone. A polyclonal staining pattern,  i.e., a 
mixture  of K-  and  k-staining  cells,  was  found  in  the  tissues  of two cases of 
Hodgkin's disease and one case of angioimmunoblastic lymphadenopathy.  One 
case of mycosis fungoides,  a  T  cell disease  (36,  37),  and several cases of other 
malignancies,  including  malignant  melanoma  and  adenocarcinoma,  showed 
replacement  of lymph  nodes  by Ig-negative  cells.  Details  of our  findings  in 
specific disease entities will be reported separately. 1020 R.  LEVY,  R.  WARNKE,  R.  F.  DORFMAN,  AND  J.  HAIMOVICH  1021 
Discussion 
A  single clone  of B  lymphoid cells  is committed to the expression of a 
particular immunoglobulin sequence of VH and VL, which together form a 
particular  antibody combining site  and impart the binding specificity  of  the Ig 
molecule (13-15,  19).  A formal proof  of  monoclonality within a population of  B 
cells  would, therefore,  require the demonstration that all the cells  were re- 
stricted  to the production of  a single  combining site,  for  instance,  by the use of 
an anti-idiotype  reagent (19,  38).  This goal  has been accomplished for human 
lymphoproliferative  diseases  in  which the immunoglobulin product is  secreted, 
such as multiple myeloma and Waldenstrom's macroglobulinemia (38,  39).  In 
these  instances,  the abundance of  the monoclonal Ig  made possible  the produc- 
tion  of  anti-idiotype  reagents  that  could  be  used  to  identify  the  malignant  clone. 
Since  many lymphoid  malignancies  are  associated  with  the  production  but  not 
the secretion  of  Ig, the use of  anti-idiotype  reagents,  while not impossible (40), 
may not  be  applicable  as a general approach  for  the diagnosis  of  monoclonality. 
For  this  reason  we and many other  investigators  (8-12,  35)  have  employed light 
chain typing as an indicator  of  monoclonality.  Here, the argument is  a statisti- 
cal  one  and  is  based  on  the  restriction  within a clone  to  the  production  of  Ig  light 
chains of  either  K or k type.  The basis  for this  restriction  is not known, and 
indeed it  may not be absolute (41,  42).  Nevertheless,  the finding  of  a uniform 
light  chain type within  a malignant lymphoid population,  while not a proof  of 
monoclonaiity,  is  taken as  strong  presumptive  evidence.  Of  course,  the demon- 
stration  of  monoclonality does not in and of  itself  make the diagnosis  of  malig- 
nancy. There  are  numerous examples  of  benign  monoclonal  lymphoproliferation 
(43).  Moreover, it  is  possible  that  malignant  transformation  could  occur  in  a cell 
that  is  a member ofa  B cell  clone  previously  expanded  by  an  antigenic  stimulus. 
In that  case  not all  the cells  bearing  the particular  Ig marker would be malig- 
nant, even though they would have arisen  from the same original  B cell.  The 
concept  of  monoclonality within human B lymphoid  malignancies  should,  there- 
fore,  be regarded as a useful  working model and not an absolute criterion  of 
malignancy. 
The unique contribution  of the present study lies  in its confirmation of 
monoclonality within human B cell  lymphomas by K/k restriction  of  the cells 
when examined in situ. Numerous previous reports  have appeared in which 
suspensions of  cells  derived from tissues  involved by lymphoma were studied 
(10-12,  35).  Here  the  imperfection  of  the K/k  statistical  argument is  compounded 
by the presence of  residual  population of  normal lymphoid cells,  some of  which 
share the light  chain type of  the lymphoma cells.  Nevertheless, in massively 
F]o. I.  Frozen section of  normal human lymph node, reactive follicle.  Immunofluorescent 
staining  was performed with a mixture of  fluorescein-labeled  F(ab')2  anti-K  and rhodamine- 
labeled F(ab')z anti-X. The same feld was photographed for fluorescein (K),  left;  and for 
rhodamine  (k),  right. There is a dense lacy network of double-staining material at the 
center of the follicle  surrounded by a  mantle of cells staining either for K or for k. 
Magnification 400. 
FIG. 2.  Frozen section of  normal human spleen follicle.  Immunofiuorescent staining  for  K 
and k as in Fig. 1. Bright autofluorescence  of  collagen in blood vessel serves as a landmark 
for orientation. Surrounding cells  are composed of a mosaic of K-staining and k-staining 
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involved tissues, clear demonstrations of K/k restrictions have been possible in 
these studies of cell suspensions. However, our results do not confirm those of 
Leech et al.  (11) who suggested, on the basis of cell suspension studies, that 
nodular lymphomas tend to be of K type and diffuse lymphomas tend to be of k 
type. 
Tissue sections have been examined by Jaffe et al.  (44), using an in situ  C'3 
rosette technique, an approach applicable only to nodular lymphomas and which 
serves to identify the nodules as being derived from germinal centers. But their 
method does not indicate the  monoclonality of the  lymphoma and does not 
distinguish between nodular lymphoma and benign lymphoid hyperplasia. Tay- 
lor and others have reported the application of an immunoperoxidase technique 
on sections of fixed, paraffin-embedded  lymphoma tissues (45, 46). While advan- 
tageous in that it can be used on previously fixed tissues, the immunoperoxidase 
technique does not allow a double-label approach, which we have found adds an 
additional dimension to the immunofluorescence  methods. Serial sections can- 
not convincingly demonstrate the mosaicism of normal lymphoid tissues with 
respect to K- and k-producing cells, which is readily apparent from double-label 
fluorescence  applied to individual sections (Figs. 1 and 2). More importantly, our 
results do not agree with those of Taylor, who reported that in nodular lym- 
phoma the nodules were composed of Ig-negative cells and the internodular 
areas were composed of monoclonal populations. Most likely these discrepancies 
arise from problems related to technique, i.e., the specificity of reagents and 
fixation of tissues.  In our study great care was taken in the preparation and 
characterization of the anti-K and anti-k reagents. The difficulty of preparing a 
reliable anti-human k reagent is not apparent from the literature. In addition, 
the use of F (ab')2 fragments of purified antibodies for direct immunofluorescence 
eliminated many of the technical difficulties previously associated with the 
technique (34). The ability to distinguish polyclonal from monoclonal staining 
on a cell-by-cell basis provided an extra measure of confidence in the results. It 
is clear that many of the reports in the literature of 20-40% Ig-bearing cells in 
normal peripheral blood  (47) are overestimates due to the artifact of passive 
absorption of serum Ig to the surface of cells (Table I) (33).  2  In addition, it is clear 
that the dense, lacy distribution of Ig in the center of reactive lymphoid follicles 
described by Braylan and Rappaport (48) and in Fig.  1 is likewise a deposit of 
extracellular protein since it stains for both K and k. 
The approach described here should be useful in the diagnosis of lymphoma, 
helping to differentiate a lymphoma from reactive hyperplasia. In addition, the 
classification of lymphomas, currently a subject of  controversy (49-53), should be 
aided by techniques, such as the one described here, which will allow the in situ 
identification of B cell neoplasms among the diffuse lymphomas as well as the 
nodular lymphomas. A growing consensus (20, 51) suggests that many ~histiocy- 
Fro.  3.  Frozen  section  of lymph  node  from  a  patient  with  diffuse,  well-differentiated 
lymphocytic lymphoma. Immunofluorescence staining as in Fig.  1. The tissue is diffusely 
infiltrated with cells staining only for K. No k-staining cells can be seen. Magnification 400. 
FIG.  4.  Frozen section of spleen from a patient with hairy cell leukemia. Immunofluores- 
cence staining as above. The tissue is diffusely infiltrated with cells staining for 4.  No K- 
staining cells are seen. Magnification 400. 1024 R.  LEVY,  R.  WARNKE,  R.  F.  DORFMAN~  AND  J.  HAIMOVICH  1025 
tic" lymphomas are, in fact, neoplasms of B lymphoid cells.  Furthermore, the 
question of clonal stability can now be raised in situations of recurrent lympho- 
mas  and  composite lymphomas.  When  treated lymphoma recurs,  does  this 
represent reappearance of the same clone or the appearance of a new malignant 
clone?  Evidence  accumulated for  Burkitt's  lymphoma seems to  imply that 
relapse occurs in the same clone for early recurrences and that new clonal 
disease accounts for late recurrences (1). 
Approximately 10-20% of human lymphoma patients have what appear to be 
two different  histologic types of lymphoma occurring simultaneously  in different 
sites (54). Are these lesions all derived from the same malignant clone or do they 
represent the simultaneous appearance of two different neoplasms? The ap- 
proach described here should provide an answer to this question. Finally, the 
ability to examine and immunologically identify the monoclonal population in 
situ should provide further insight into the pattern of involvement and spread of 
human lymphomas within the lymphoid architecture. 
Summary 
Human tissues involved with lymphoma have been examined in frozen sec- 
tions for immunoglobulin-bearing cells by a  technique involving double-label 
immunofluorescence  with mixed anti-K and anti-k antibodies. F(ab'h fragments 
of purified antibodies were employed to avoid any binding via Fc receptors. B 
cell lymphomas were shown to be composed of monoclonal populations of Ig- 
bearing cells, whereas normal or reactive lymphoid follicles contained a mosaic 
of Ig-bearing cells derived from multiple clones.  Nodules of lymphoma were 
often surrounded by normal polyclonal B cell populations.  We anticipate that 
the  approach  described here  will  be  useful  in  the  diagnosis  of lymphoma, 
differentiating it from reactive lymphoid hyperplasia by the demonstration of 
monoclonality. In addition, it should provide a  sensitive and reliable tool for 
investigating the immunobiology of human lymphoma. 
The authors gratefully acknowledge the technical assistance of Mr.  Moshe Rotman, Mrs. Meme 
Pederson, and Mrs. Dede Rice, the photography of Mr. Philip Horn, and the secretarial assistance 
of Ms. Linda Puffer. 
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